Sir Run Run Shaw Hospital

People's Republic of China

Country: People's Republic of China

Ownership: Private

Established: 1994-01-01

Employees: -

Market Cap: -

Website: http://www.srrsh.com/html/main/gb2312/

Clinical Trials

Clinical Study of Umbilical Cord Mesenchymal Stem Cells Combined With Collagen Scaffold in the Treatment of Thin Endometrium

Not Applicable

Completed

Conditions: Intrauterine Adhesion
Thin Endometrium

Interventions: Drug: umbilical cord mesenchymal stem cells combined with collagen scaffold

First Posted Date: 2018-10-30

Last Posted Date: 2021-04-13

Lead Sponsor: Sir Run Run Shaw Hospital

Target Recruit Count: 18

Registration Number: NCT03724617

Locations: 🇨🇳
Sir Run Run Shaw hopital,School of medicine,Zhejiang University, Hangzhou, China

Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Malignant Tumor

Phase 1

Conditions: Advanced Malignant Solid Tumor

Interventions: Biological: iNeo-Vac-P01
Other: GM-CSF

First Posted Date: 2018-09-07

Last Posted Date: 2021-11-16

Lead Sponsor: Sir Run Run Shaw Hospital

Target Recruit Count: 30

Registration Number: NCT03662815

Locations: 🇨🇳
Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China

Epidemiology of Klebsiella Pneumoniae in China

Conditions: Klebsiella Pneumoniae Infection

Interventions: Other: no intervention

First Posted Date: 2018-07-26

Last Posted Date: 2018-07-26

Lead Sponsor: Sir Run Run Shaw Hospital

Target Recruit Count: 100

Registration Number: NCT03598543

Locations: 🇨🇳
Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China

Boosting Chinese Healthcare Service Providers' Utilization of Smoking Cessation Interventions by 'WeChat WeQuit' Program

Not Applicable

Conditions: Smoking Abstinence
Smoking Cessation Intervention

Interventions: Behavioral: 'WeChat WeQuit' smoking cessation training program

First Posted Date: 2018-06-14

Last Posted Date: 2020-08-12

Lead Sponsor: Sir Run Run Shaw Hospital

Target Recruit Count: 2200

Registration Number: NCT03556774

Locations: 🇨🇳
Yanhui Liao, Hangzhou, Zhejiang, China

Efficacy of Low-FODMAPs Dietary Therapy for Irritable Bowel Syndrome in China

Not Applicable

Completed

Conditions: Diet Modification
Irritable Bowel Syndrome

Interventions: Dietary Supplement: low-FODMAPs diet
Dietary Supplement: Traditional dietary advice

First Posted Date: 2017-10-06

Last Posted Date: 2019-09-12

Lead Sponsor: Sir Run Run Shaw Hospital

Target Recruit Count: 108

Registration Number: NCT03304041

Locations: 🇨🇳
Sir Run Run Shaw Hospital , College of Medicine, Zhejiang University, Hangzhou, Zhe Jiang, China

Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China

Conditions: Klebsiella Pneumoniae Infection

Interventions: Other: Carbapenem-Resistant Klebsiella pneumoniae

First Posted Date: 2017-08-10

Last Posted Date: 2017-08-10

Lead Sponsor: Sir Run Run Shaw Hospital

Target Recruit Count: 800

Registration Number: NCT03245632

Locations: 🇨🇳
Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China

'WeChat WeQuit' Smoking Cessation Program

Not Applicable

Completed

Conditions: Cigarette Smoking
Smoking Cessation

Interventions: Behavioral: Cognitive and Behavioral Intervention

First Posted Date: 2017-05-30

Last Posted Date: 2022-12-02

Lead Sponsor: Sir Run Run Shaw Hospital

Target Recruit Count: 2000

Registration Number: NCT03169686

Locations: 🇨🇳
Yanhui Liao, Hanzhou, Zhejiang, China

A Clinical Trial of Apatinib Plus Docetaxel in Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma

Phase 1

Conditions: Metastatic Gastric Adenocarcinoma

Interventions: Drug: Apatinib
Drug: Docetaxel

First Posted Date: 2017-03-06

Last Posted Date: 2017-03-06

Lead Sponsor: Sir Run Run Shaw Hospital

Target Recruit Count: 12

Registration Number: NCT03071042

Locations: 🇨🇳
Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China

CA-MRSA Infection in China: Epidemiology, Molecular Characteristics, Treatment, and Outcome

Conditions: Community-Acquired Infections
Methicillin-resistant Staphylococcus Aureus

Interventions: Other: None Intervention

First Posted Date: 2017-02-27

Last Posted Date: 2017-02-27

Lead Sponsor: Sir Run Run Shaw Hospital

Target Recruit Count: 5400

Registration Number: NCT03064464

Locations: 🇨🇳
Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China

Intensive Blood PRessure Control in Patients With Acute Type B AortIc Dissection

Phase 1

Conditions: Blood High Pressure
Aortic Dissection Type B

Interventions: Drug: Urapidil Hydrochloride Injection

First Posted Date: 2016-12-23

Last Posted Date: 2016-12-23

Lead Sponsor: Sir Run Run Shaw Hospital

Target Recruit Count: 360

Registration Number: NCT03001739

Locations: 🇨🇳
Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy